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Abstract. Human artificial chromosomes (HACs) were gen-
erated by transfer of telomerized PAC constructs containing
alpha satellite DNA of various human chromosomes. To moni-
tor which cells took up constructs and subsequently formed sta-
ble clones under blasticidin S (BS) selection, a CMV/EGFP
expression cassette was inserted into a HAC construct based on
chromosome 5 alpha satellite DNA (142 kb). Lipofection into
HT1080 cells resulted in a small proportion of cells exhibiting
bright green fluorescence on day 1. Areas containing such early
green cells were marked, and plates monitored over 2 weeks. In
only one out of 41 marked areas, a viable clone developed. In
the remaining 40 areas, the green cells ceased division at 1–8
cells. In contrast, outside the marked areas, 16 stable clones
formed which did not exhibit green fluorescence during the
first cell divisions, but all cells of each became green around day
4–6. Fluorescence in situ hybridization (FISH) analysis of iso-
lated clonal lines demonstrated low copy HAC formation with-
out integration. We conclude that transient expression of an
EGFP marker on HAC DNA is not a suitable means for the
identification of the proportion of transfected cells which are
capable of forming viable clones. One explanation could be that
the high copy number required to consistently detect transient
EGFP expression (Schindelhauer and Laner, 2002) impairs
viability and clone formation.
Copyright © 2004 S. Karger AG, Basel
Human artificial chromosomes (HACs) represent an ideal
tool to stably add genetic material to cells without integration
into host chromosomes. While existing chromosomes, includ-
ing small marker chromosomes, can be modified and moved
between cultured cells, the de novo formation of HACs offers
the opportunity to assemble novel chromosomes from isolated
DNA sequences. Hitherto, a variety of chromosome-specific
alpha satellite DNA arrays of various human chromosomes,
including chromosomes 2, 5, 8, 11, 15, 19, 21, 22, X, and Y
have been transferred as purified DNA in order to form cen-
tromeres of de novo HACs (Harrington et al., 1997; Ikeno et al.,
1998; Henning et al., 1999; Ebersole et al., 2000; Schueler et al.,
2001; Grimes et al., 2002; Mejia et al., 2002; Ohzeki et al.,
2002; Kouprina et al., 2003). HACs have been obtained with
circular constructs containing alpha satellite DNA as the only
human sequence component (Ebersole et al., 2000), demon-
strating the pivotal role of a functional centromere, or with
linearized alpha satellite constructs containing telomere se-
quences and/or genomic copies of genes (Grimes et al., 2001;
Mejia et al., 2001; Ikeno et al., 2002).
The de novo formation of HACs involves a process of chro-
matinization. It is known that attracting nuclear proteins in the
target cells is facilitated by chromosome functional sequences
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(telomeres, centromeres). Usually, input molecules tend to
form concatemers (Harrington et al., 1997; Ikeno et al., 1998;
Mejia et al., 2001; Rudd et al., 2003), and the efficiency of the
formation of a stable clone may depend on the load and struc-
ture of the transferred DNA, which might interfere with subse-
quent cell division, for example due to irreparable double
strand breaks.
Using current techniques, the proportion of cells which
form HACs is still rather small. To develop efficient HAC
transfer, it would be helpful to know which cells on a plate
actually took up the DNA constructs, and what proportion of
such physically successfully transfected cells are capable of
developing viable clones. This would help to distinguish be-
tween the very different barriers to the formation of a stable
clone, that is the physical transfer at all, the physical transfer of
a supportive copy number, and the capacity of the transferred
DNA sequence to acquire genetic function. 
Here we analyze whether a CMV/EGFP expression cassette
present on large HAC constructs (142 kb) could be used to
monitor lipofected HT1080 cells over the time. The specific
question was whether transient expression from HAC con-
structs, visible under the microscope one day after lipofection,
was a measure of the number of physically successfully trans-
fected cells, and how many of these cells would form stable
clones. We questioned this, because we recently found that a
high copy number (1103) of the CMV/EGFP expression cas-
sette present on linear or circular plasmid DNA (pEGFP-N1,
Clontech) is required to detect green fluorescence at day 1 in
the majority of cells (HT1080 and other cell types), which phys-
ically obtained the DNA by intranuclear microinjection (Schin-
delhauer and Laner, 2002). Transfection of HAC constructs in
this copy number range (103 per cell) would require transfer of a
large amount of DNA, since the 1.7-kb-sized CMV/EGFP/
SV40-polyA expression cassette occupies only 1.2% of the
HAC construct, compared to 36% of the EGFP-N1 plasmid.
One thousand copies of the construct TTE1 used in this study
would for example exceed the content of one replicated human
chromosome 20. However, such a calculation may be mislead-
ing, as the DNA fraction physically transferred to the nucleus
after lipofection is unknown. In addition, a copy number-
dependent transient expression has not been observed for very
high DNA loads, using lipofection of 1 Ìg of EGFP plasmid per
1.5 cm well (570 ng/cm2) or a 24-fold dilution (Walker et al.,
2004).
Materials and methods
Vector construction
P1 phage based artificial chromosomes (PACs) (Ioannou et al., 1994),
known to allow stable cloning of long arrays of highly homogeneous centro-
meric tandem repeat arrays in E. coli (Schindelhauer and Schwarz, 2002),
were used for construction. HAC construct TTE1 (142 kb) contains a 116-kb
·-satellite array from chromosome 5, belonging to the subtype of the dimeric
alpha satellite family present on human chromosomes 1, 5, and 19 (Archidia-
cono et al., 1995). The homogeneous array in construct TTE1 contains
0.34 kb EcoRI higher order repeats as revealed by restriction analysis (not
shown). TTE1 was isolated from PAC library RPCI 704 (Ioannou et al., 1994)
by array-specific PCR using primers 5IF (5)-GTG AGG AAA CAG TCT
GTT TGT C) and 5IR (5)-GAA TCA TTC TGT CTA GTT TTT ATA C).
Primer sequences were derived by sequencing the 0.7-kb insert of plasmid
pZ5.1 (Hulsebos et al., 1995; http://www.biologia.uniba.it/rmc/5-alfoidi/
-alfoidiplasmids.html, EMBL/GenBank accession number AJ717298). The
NotI insert of PAC E1 (116 kb) has been cloned into the Bsp120I site of pTT
(26 kb), a tetratelomeric PAC vector, which was generated from the ditelo-
meric PAC vector pTAT-BS (17 kb, Ebersole et al., 2000; EMBL/GenBank
accession numbers BN000528 and BN000529), by insertional duplication of
the portion between the telomeres, insertion of a prokaryotic white/blue
selectable marker derived from pUC19 (Gibco BRL), and insertion of an
eukaryotic CMV/EGFP expression cassette (1.7 kb) derived from plasmid
pEGFP-N1 (Clontech) by PCR with primers GGF (5)-CCT GAT TCT CGA
GAT AAC CGT ATT ACC GCC ATG) and GGR (5)-GGA TAG TGG AGT
CGA CTT CCA AAC TGG AAC AAC ACT C). The duplicated arrangement
of vector sequences resulted in the presence of two copies of the blasticidin S
(BS)-selectable marker, while only one copy of the EGFP cassette is present
(see Fig. 1b). Function of the EGFP cassette within the sequence context of
vector pTT was checked using intranuclear microinjections (104–105 copies
per injection volume) and transient expression analysis according to the
assay previously described (Schindelhauer and Laner, 2002). 
PAC DNA preparation
Pure intact TTE1 DNA was prepared from agarose plugs as described
(Schindelhauer and Cooke, 1997). E. coli DH10B (Gibco BRL) harboring
PAC TTE1 were grown overnight in 50 ml LB supplemented with ampicillin
(Sigma; 100 Ìg/ml) and kanamycin (Sigma; 30 Ìg/ml). After 12 h, 200 ml of
fresh LB amp/kana was added and incubated for 2–3 h at 37 °C. 30 min
before harvest, 84 Ìg/ml chloramphenicol (Sigma) was added in order to
complete ongoing PAC replication without re-initiation. Cells were centri-
fuged (Beckman J-21B; 4,000 rpm, 15 min, 4 ° C), resuspended in 10 ml buff-
er Pett IV (10 mM Tris, pH 7.4; 1 M NaCl) and washed by centrifugation
(4,000 rpm, 15 min, 4 °C). The pellet was resuspended 1:1 (v/v) in Pett IV
(42 °C) and the suspension mixed 1:1 (v/v) with 2% low melting point aga-
rose (Gibco BRL; “ultrapure”, melted and cooled to 42 °C). Plugs were
allowed to set on ice in disposable plug molds (Biorad), and transferred to
30 ml EC-Lysis buffer (6 mM Tris, pH 7.4; 1 M NaCl; 100 mM EDTA, pH
7.8; 0.5% Brij 58; 0.2% deoxycholate; 0.5 % N-lauroyl-sarkosin) freshly sup-
plemented with lysozyme (Fluka BioChemika; 50 Ìg/ml) and RNase A
(Roche; 10 Ìg/ml) and incubated for 12–24 h at 37 °C. To remove cell debris,
plugs were incubated for 2 days in 20 ml of buffer NDS (0.5 M EDTA, pH 9;
after sterilization 1 % N-lauroyl-sarkosin) containing proteinase K (ICN;
10 Ìg/ml) at 50 ° C, and for 2 weeks at room temperature (RT) changing NDS
every 2 days. Plugs were stored in NDS at RT in the dark. To remove E. coli
DNA and nicked or broken PACs, the E. coli DNA was linearized using AscI
(does not cut in the PAC) according to the manufacturer’s instructions, and
removed from the plugs by pulsed field gel electrophoresis (1–60 s switch
time, 6 V/cm, 16 h, 0.5× TAE). Telomerized constructs were isolated by NotI
digestion (New England Biolabs), pulsed field separation (1–30 s switch time,
6 V/cm, 16 h) (see Fig. 1c), and electroelution in 0.25× TAE using a BioTrap
BT1000 (Biometra).
Cell culture, lipofection and selection of stable cell lines
HT1080 cells were grown in DMEM (Gibco BRL) supplemented with
10 % FCS (Biochrom, Berlin, Germany) and 2 % (v/v) penicillin/streptomy-
cin (Gibco BRL). Petri dishes (75 cm2) containing approximately 5 × 105
HT1080 cells (F50 % confluency) were washed with PBS (Gibco BRL). For
each plate, 10 Ìl LipofectAMINE Reagent™ (Gibco BRL) and 190 Ìl Opti-
MEM-I (Gibco BRL) were thoroughly mixed and incubated for 25 min at
RT. 5 min prior to transfection, the DNA solution was prepared using
approximately 150 ng of TTE1 DNA (in 0.25× TAE) added to OptiMEM-I
resulting in a volume of 200 Ìl. The DNA was gently mixed with the lipofec-
tion mixture and incubated for 5 min at RT. The solution was added to the
cells with 2 ml OptiMEM-I. Plates were placed on a support leveled to obtain
an equal distribution of liposome complexes (F2 ng DNA/cm2), and incu-
bated at 37 ° C. After 12 h, cells were washed with medium and incubated for
1 day without selection, and for 14 days in medium supplemented with
4 Ìg/ml blasticidin S (ICN), which was changed every second day. Individual
colonies were picked and subsequently expanded in 6-well dishes and T25-
flasks until 30 days of growth for FISH analysis.
Monitoring transient expression and stable clone formation
Transfected plates were screened every day by bright field and fluores-
cence microscopy using a Zeiss Axiovert 10 equipped with a HBO 50 lamp
Cytogenet Genome Res 107:9–13 (2004) 11
Fig. 1. Monitoring expression from an EGFP cassette present on a HAC
construct. (a) Sections of 50 % of eight plates (n10 cm) containing approxi-
mately 5 × 105 HT1080 cells were taped to exclude light damage from daily
bright field and fluorescence microscopy screens. Per plate, F150 ng of NotI
cut, electroeluted TTE1 was lipofected, and EGFP expression and clone for-
mation screened over a period of 14 days. At day 1, 41 “early” green cells
(either singletons or doublets) were identified and areas marked (n5 mm,
indicated as small gray dots). At day 14, only one viable green colony had
developed in such an early marked area (not illustrated). In 40 areas, the
green cells ceased growth, mostly at the 1–2 or up to 8 cell stage (indicated as
small gray dots with an X). Outside of the marked areas, 16 viable clones
developed, but EGFP expression became detectable not before a multiple
cell stage (8–32) between days 4 and 6 (indicated as quadruplet gray dots at
day 6). These “late” green cells grew under selection and resulted in uniform-
ly green, viable colonies at day 14 (illustrated as large gray dots). At day 14, a
similar picture was observed in the uncovered control sections. (b) Schematic
drawing of the tetratelomeric HAC construct TTE1. The 142-kb-sized PAC
contains four arrays of (TTAGGG)135 (tel), a duplicated arrangement of vec-
tor sequences with 2 copies of the blasticidin S resistance marker (BS), and a
CMV/EGFP expression cassette (EGFP). A 116-kb alpha satellite array of
human chromosome 5 (black bar) was cloned from a PAC (E1) by conven-
tional cloning. The PAC backbone (P1) is removed by NotI restriction, result-
ing in a 133-kb-sized, telomerized HAC construct. (c) Integrity of the NotI
fragment was checked on a pulsed field gel prior to lipofection (M, Midrange
Marker II, NEB). Approximately the 100-fold amount of DNA was loaded on
a quantitative pulsed field gel and excised without UV illumination for elec-
troelution (not shown). (d) Two EGFP expressing (late) lines, TTE1-12 and
TTE1-14, were picked and expanded for 30 days (approximating 30 genera-
tions). Metaphase spreads (n 1 15) were analyzed by FISH using alpha satel-
lite probe cen5I (from PAC E1) staining the centromeres of chromosomes 1,
5, and 19, and vector probe Rsf including the BS selectable marker. Both
probes showed colocalization on low copy, episomal DAPI elements without
integration into host chromosomes, demonstrating HAC formation in both
lines. Shown is a typical HAC (arrow) in a metaphase of line TTE1-14 (inset:
magnification of the HAC).
and filter set F41-018 (HQ 470/40, 495, HQ 500 LP) in a dark room. Cells
expressing at day 1 were marked by circles and plates were monitored over a
period of 14 days. In order to exclude light damage by frequent illumination,
the dish bottoms were taped half (Fig. 1a). At day 14, the taped sections were
uncovered, and the plates were screened for individual cells and colonies
using bright field and fluorescence microscopy.
FISH analysis
Cells enriched for metaphases using 0.4 mg/ml Colcemid (Roche) for 4 h,
were treated at 37 ° C for 40 min in 0.8% (w/v) sodium citrate. Nuclei were
fixed in methanol:acetic acid (3:1) at –20 °C for standard chromosomal
spreads. RNase A and pepsin (Roche) treated chromosome preparations
were dehydrated in ethanol. Chromosomal DNA and probes were simulta-
neously denatured at 72 °C for 5 min in 50 % (v/v) formamide, 2× SSC, 20 %
(w/v) dextran sulfate and incubated in a humid chamber at 37 °C for 72 h.
FISH hybridization was carried out in the presence of 1 mg/ml salmon testes
DNA (Sigma). Post-hybridization washes were carried out in 4× SSC, 0.2 %
(v/v) Tween-20 and in 2× SSC, 50% formamide at 42 ° C. After blocking with
3% (w/v) BSA, Cy3.5-conjugated avidin (Rockland, Gilbertsville) or FITC-
conjugated anti-digoxigenin antibody (Roche) was bound in 1% (w/v) BSA,
4× SSC, 0.2% (v/v) Tween-20. Slides were washed (4× SSC, 0.2% Tween-20,
42 °C) and counterstained with DAPI (4),6-diamidino-2-phenylindole; Sig-
ma), mounted with antifade (PPD) and analyzed on a Leica DM RXA with a
CCD camera controlled by Q-FISH software (Leica Microsystems). The vec-
tor probe Rsf was derived by PCR from pTAT-BS using primer Rsf (5)-AGC
GGT CGG ACC GTG CTC), which amplifies a 3.15-kb vector fragment
spanning the BS selectable marker. The PCR product was labeled by incorpo-
ration of biotin-16-dUTP (Roche) in a PCR reaction. Probe cen5I was ampli-
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fied from PAC E1 using primers 5IF/R and labeled by PCR incorporation of
digoxygenin-11-dUTP (Roche). Note that the signals of the vector probe are
usually scaled up, while the centromere signals are kept at low intensity to
minimize cross-hybridization with the alpha satellite arrays of other chromo-
somes.
Results
Lipofection of the telomerized artificial chromosome con-
struct TTE1 gave rise to 41 bright green cells (1–12 per half
plate, on 8 plates, from 2 experiments) 24 h after transfer. Areas
of F5 mm diameter were marked around the early green cells
in order to investigate cell growth over the course of time (illus-
trated as small gray dots in Fig. 1a). Most of the marked areas
contained either single or doublet (n = 37) green cells at day 1
post transfection which ceased growth at this stage. A minority
of the early green cells divided to 4 or 8 cells (n = 4) by day 6,
but finally also stopped dividing. During subsequent incuba-
tion under selection, all cells surrounding the green cells died
and detached, excluding any resistant cells growing without
expressing EGFP. At day 14, only one of the 41 early green
areas contained a growing colony. However, outside of the
marked areas, where no green cells were detected at day 1, 16
viable clones developed (0–7 per half plate). These colonies
were not fluorescent before day 4–6, at which time they com-
prised 8–32 cells (illustrated as groups of 4 gray dots in Fig. 1a).
Strikingly, the cells of the viable clones became successively
brighter and appeared uniformly green. All 16 clones grew until
day 14. No stable clone was observed, which did not become
green. At day 14, the taped areas were uncovered and also
screened; 9 viable clones and 29 green cells that ceased growth
at the 1–8 cell stage were detected.
Two such green clones (TTE1-12 and -14) were picked and
expanded for 30 days under BS selection (approximating 30
generations). After this period, the cell lines showed bright and
uniformly green cells, indicating stable inheritance of the BS-
selectable marker and of the adjacent EGFP cassette, as well as
stable expression from the construct. In order to distinguish
between HAC formation and integration into host chromo-
somes, the two expanded late green lines were analyzed by dual
color FISH using cen5I (green) and PAC vector (red) probes.
Both probes stained low copy (probably one per cell), episomal
DAPI-positive HACs in the lines TTE1-12 and TTE1-14
(Fig. 1d; white arrow), without integration into host chromo-
somes in all metaphases analyzed (n 1 15). The data demon-
strate the formation of stably segregating HACs in the ex-
panded clones, which arose from areas of the plate where no
early green cells could be detected.
Discussion
In order to check the usefulness of a CMV/EGFP expression
cassette present on a HAC construct for monitoring physical
transfer and clone formation, we lipofected the PAC construct
TTE1 into the human lung sarcoma cell line HT1080. Expres-
sion was monitored by fluorescence microscopy from an early,
transient stage at day 1 post transfection until formation of sta-
ble clones. Using this simple assay, we made the striking obser-
vation that the transfer events allowing early detection via tran-
sient expression, and the transfer events leading to stably
expressing clones were mutually exclusive. Cells which were
fluorescent at day 1 ceased growth, and cells that led to stable
clones where not detectable at day 1, but became fluorescent by
day 4–6 after several cell divisions (with one exception). Since
the numbers of green cells that ceased growth, and that of stable
colonies, were comparable in the taped and illuminated sec-
tions (both types of transfectants were somewhat less in the
dark sections, possibly due to inaccurate leveling), a negative
effect of daily illumination on cell viability and clone formation
was excluded. As viable clones developed strong expression at a
later stage, it is also excluded that any toxicity of EGFP protein
could have impaired cell division in HT1080. More likely, ear-
ly transient expression was indicative for a type of transfection
event not supporting viable clones, possibly due to a high DNA
load.
Previous studies using direct physical transfer by intranu-
clear microinjection and analysis of transient expression
showed that low copy numbers of the EGFP expression cassette
present on a small plasmid are not suitable to detect presence of
constructs in the majority of cells surviving injection. Consis-
tently, copy numbers of 103 per nucleus were required in var-
ious cell types including HT1080, and 104 or 105 copies led to
brighter signals, detectable within 2 h post injection. However,
in a small fraction of F5% of microinjected cells, exceptionally
high expression occurred, which allowed the detection of as few
as 10–100 copies (Schindelhauer and Laner, 2002). According
to these experiments, it is obvious that the number of cells
showing transient expression can be highly variable (0–100%),
even if 100% of cells physically obtained a copy number some-
where between 1 and 103.
By analogy to the microinjection assay, one could argue that
most of the early green cells from the present study might have
received high copy numbers of the HAC construct, while the
clone forming cells received low copy numbers. However, it
could be that the 41 early green cells belonged to a much larger
fraction with moderate copy numbers, out of which only a
small set was detectable due to exceptionally high expression
(according to 10–100 plasmid copies being detectable in F5%
of cells in a microinjection, see Schindelhauer and Laner,
2002). In this case, a large number of physically transfected
cells would not be detected by transient expression. Possibly,
the cells capable of forming stable clones might have derived
from such a larger fraction with a moderate or low copy num-
ber.
One hint supporting clone formation from low copy num-
bers is the observation that microinjection of only 1–10 HAC
molecules per nucleus resulted in one stable clone per 400–500
injections (unpublished data; Ikeno et al., 1998). Given that
only 50–90% of injected HT1080 cells immediately survive
injection (Schindelhauer and Laner, 2002), and some nuclear
destruction might further reduce the rate of long term viability,
clone formation per se could well exceed the level of one or a
few percent.
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Conclusions
We conclude that early transient expression of a CMV/
EGFP expression marker present on a HAC is not a suitable
means for detecting the fraction of transfected cells which sub-
sequently form viable clones. In contrast, there is a striking
inability of early green cells (presumably higher copy) to form
stable clones, whereas cells with undetectable fluorescence
before day 4–6 (presumably lower copy) can form viable clones,
which turn green at a multiple-cell stage, on the base of stable
inheritance of expressing HACs. Thus, cells should be moni-
tored for at least 6 days (i.e. generations), if aiming at the detec-
tion of functional HAC transfer. This would help to distinguish
the stable expression in viable clones from the cells with a
bright mark of death.
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